Iradimed (IRMD) Short-term Investments (2013 - 2022)

Iradimed (IRMD) has 10 years of Short-term Investments data on file, last reported at $500090.0 in Q1 2022.

• Short-term Investments for Q1 2022 came in at $500090.0, down 73.72% year-over-year; the trailing twelve-month figure through Mar 2022 was $500090.0 (down 73.72% YoY), and the FY2021 annual result was $501855.0, down 73.72% from the prior year.
• Short-term Investments was little changed at $500090.0 in Q1 2022 per IRMD's latest filing, from $501855.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $8.2 million in Q2 2018 and troughed at $500090.0 in Q1 2022.
• A 5-year average of $3.6 million and a median of $2.8 million in 2019 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2018 and 2022: Short-term Investments increased 16.34% in 2018, then slumped 73.72% in 2022.
• A 5-year view of Short-term Investments shows it stood at $6.3 million in 2018, then plunged by 56.4% to $2.8 million in 2019, then plunged by 31.03% to $1.9 million in 2020, then sank by 73.72% to $501855.0 in 2021, then fell by 0.35% to $500090.0 in 2022.
• Business Quant data shows IRMD's Short-term Investments at $500090.0 in Q1 2022, $501855.0 in Q4 2021, and $945066.0 in Q3 2021.